Skip to main content
. 2019 Mar 6;10:315. doi: 10.3389/fimmu.2019.00315

Figure 5.

Figure 5

The effect of ATG brand and dosing on acute GvHD. Although not significant, acute GvHD (grade II-IV) occurred less frequently in ATG Genzyme high dose (ATG-GENZ-high) receiving patients compared to patients receiving a low dose of ATG-Genzyme (ATG-GENZ-low) or ATG Fresenius (ATG-FRES). For severe acute GvHD (grade III-IV), there was a significant difference between the three ATG groups. Severe acute GvHD occurred most frequently in the ATG-GENZ-low group.